Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Shares, nominal value (euro)0.12 per share
-
Shares outstanding
-
67,811,197
-
Total 13F shares
-
16,811,412
-
Share change
-
-705,379
-
Total reported value
-
$13,281,301
-
Put/Call ratio
-
0%
-
Price per share
-
$0.79
-
Number of holders
-
27
-
Value change
-
-$1,273,661
-
Number of buys
-
15
-
Number of sells
-
20
Institutional Holders of InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) as of Q2 2025
As of 30 Jun 2025,
InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,811,412 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, 683 Capital Management, LLC, RA CAPITAL MANAGEMENT, L.P., Eversept Partners, LP, Woodline Partners LP, Ikarian Capital, LLC, MORGAN STANLEY, RAYMOND JAMES FINANCIAL INC, ADAGE CAPITAL PARTNERS GP, L.L.C., and DAFNA Capital Management LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.